198 related articles for article (PubMed ID: 9355935)
1. Cataract development induced by repeated oral dosing with FK506 (tacrolimus) in adult rats.
Ishida H; Mitamura T; Takahashi Y; Hisatomi A; Fukuhara Y; Murato K; Ohara K
Toxicology; 1997 Dec; 123(3):167-75. PubMed ID: 9355935
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of an aldose reductase inhibitor on lens metabolism, ATPases and antioxidative defense in streptozotocin-diabetic rats: an intervention study.
Obrosova IG; Fathallah L
Diabetologia; 2000 Aug; 43(8):1048-55. PubMed ID: 10990083
[TBL] [Abstract][Full Text] [Related]
3. Effect of instillation of aldose reductase inhibitor FR74366 on diabetic cataract.
Ao S; Kikuchi C; Ono T; Notsu Y
Invest Ophthalmol Vis Sci; 1991 Nov; 32(12):3078-83. PubMed ID: 1834606
[TBL] [Abstract][Full Text] [Related]
4. Na+-K+-ATPase pumping activity is not directly linked to myo-inositol levels after sorbinil treatment in lenses of diabetic rats.
Yeh LA; Rafford CE; Goddu KJ; Ashton MA; Beyer TA; Hutson NJ
Diabetes; 1987 Dec; 36(12):1414-9. PubMed ID: 2824260
[TBL] [Abstract][Full Text] [Related]
5. Nonosmotic diabetic cataracts.
Malone JI; Lowitt S; Cook WR
Pediatr Res; 1990 Mar; 27(3):293-6. PubMed ID: 2138728
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of osmotic and oxidative stress in slow-developing cataract formation.
Chan AW; Ho YS; Chung SK; Chung SS
Exp Eye Res; 2008 Nov; 87(5):454-61. PubMed ID: 18760274
[TBL] [Abstract][Full Text] [Related]
7. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.
Kador PF; Lee JW; Fujisawa S; Blessing K; Lou MF
J Ocul Pharmacol Ther; 2000 Apr; 16(2):149-60. PubMed ID: 10803425
[TBL] [Abstract][Full Text] [Related]
8. Effects of a novel potent aldose reductase inhibitor, GP-1447, on aldose reductase activity in vitro and on diabetic neuropathy and cataract formation in rats.
Ashizawa N; Yoshida M; Sugiyama Y; Akaike N; Ohbayashi S; Aotsuka T; Abe N; Fukushima K; Matsuura A
Jpn J Pharmacol; 1997 Feb; 73(2):133-44. PubMed ID: 9074947
[TBL] [Abstract][Full Text] [Related]
9. Osmotic stress, not aldose reductase activity, directly induces growth factors and MAPK signaling changes during sugar cataract formation.
Zhang P; Xing K; Randazzo J; Blessing K; Lou MF; Kador PF
Exp Eye Res; 2012 Aug; 101():36-43. PubMed ID: 22710095
[TBL] [Abstract][Full Text] [Related]
10. GP-1447, an inhibitor of aldose reductase, prevents the progression of diabetic cataract in rats.
Kawakubo K; Mori A; Sakamoto K; Nakahara T; Ishii K
Biol Pharm Bull; 2012; 35(6):866-72. PubMed ID: 22687477
[TBL] [Abstract][Full Text] [Related]
11. Zopolrestat prevention of proteinuria, albuminuria and cataractogenesis in diabetes mellitus.
Beyer-Mears A; Mistry K; Diecke FP; Cruz E
Pharmacology; 1996 May; 52(5):292-302. PubMed ID: 8807673
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of lower doses of vanadium in restoring altered glucose metabolism and antioxidant status in diabetic rat lenses.
Preet A; Gupta BL; Yadava PK; Baquer NZ
J Biosci; 2005 Mar; 30(2):221-30. PubMed ID: 15886458
[TBL] [Abstract][Full Text] [Related]
13. Beneficial influence of fungal metabolite nigerloxin on eye lens abnormalities in experimental diabetes.
Suresha BS; Sattur AP; Srinivasan K
Can J Physiol Pharmacol; 2012 Apr; 90(4):387-94. PubMed ID: 22423974
[TBL] [Abstract][Full Text] [Related]
14. Antioxidant potential of fungal metabolite nigerloxin during eye lens abnormalities in galactose-fed rats.
Suresha BS; Srinivasan K
Curr Eye Res; 2013 Oct; 38(10):1064-71. PubMed ID: 23767695
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of diabetic-cataract by vitamin K1 involves modulation of hyperglycemia-induced alterations to lens calcium homeostasis.
Sai Varsha MK; Raman T; Manikandan R
Exp Eye Res; 2014 Nov; 128():73-82. PubMed ID: 25257692
[TBL] [Abstract][Full Text] [Related]
16. The possible mechanism of naphthalene cataract in rat and its prevention by an aldose reductase inhibitor (ALO1576).
Xu GT; Zigler JS; Lou MF
Exp Eye Res; 1992 Jan; 54(1):63-72. PubMed ID: 1541342
[TBL] [Abstract][Full Text] [Related]
17. Interaction between osmotic and oxidative stress in diabetic precataractous lens: studies with a sorbitol dehydrogenase inhibitor.
Obrosova IG; Fathallah L; Lang HJ
Biochem Pharmacol; 1999 Dec; 58(12):1945-54. PubMed ID: 10591149
[TBL] [Abstract][Full Text] [Related]
18. CP-45,634: a novel aldose reductase inhibitor that inhibits polyol pathway activity in diabetic and galactosemic rats.
Peterson MJ; Sarges R; Aldinger CE; MacDonald DP
Metabolism; 1979 Apr; 28(4 Suppl 1):456-61. PubMed ID: 122297
[TBL] [Abstract][Full Text] [Related]
19. Vitamin K1 prevents diabetic cataract by inhibiting lens aldose reductase 2 (ALR2) activity.
Thiagarajan R; Varsha MKNS; Srinivasan V; Ravichandran R; Saraboji K
Sci Rep; 2019 Oct; 9(1):14684. PubMed ID: 31604989
[TBL] [Abstract][Full Text] [Related]
20. Reduction of oxidative-nitrosative stress underlies anticataract effect of topically applied tocotrienol in streptozotocin-induced diabetic rats.
Abdul Nasir NA; Agarwal R; Sheikh Abdul Kadir SH; Vasudevan S; Tripathy M; Iezhitsa I; Mohammad Daher A; Ibrahim MI; Mohd Ismail N
PLoS One; 2017; 12(3):e0174542. PubMed ID: 28350848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
